JPRN-UMIN000046309尚未招募Unknown
The effect of semaglutide on liver function in NAFLD patietns with DM - The effect of semaglutide on liver function in NAFLD patietns with DM
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Liver cirrhosis Patients deemed inappropriate by the physician
研究者
相似试验
尚未招募
不适用
Effect of oral semaglutide on hepatic fibrosis of type 2 diabetes patients with NAFLDtype 2 diabetes patients with NAFLDJPRN-UMIN000046994Shizuoka General Hospital, Center for Diabetes, Endocrinology and Metabolism50
进行中（未招募）
1 期
The effect of semaglutide therapy on hepatic fat content and on the acute response of liver fat to high-fat loadMedDRA version: 20.0Level: PTClassification code: 10029883Term: Obesity Class: 100000004861ObesityCTIS2023-504988-16-00Institut Klinicke A Experimentalni Mediciny16
招募中
不适用
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes MellitusDiabete MellitusLiver Transplant ComplicationsNCT06060392Medanta, The Medicity, India50
进行中（未招募）
1 期
A research study to compare a medicine called semaglutide against placebo in people with peripheral arterial disease and type 2 diabetesPeripheral arterial diseaseDiabetes Mellitus, Type 2MedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-003399-38-HUovo Nordisk A/S800
进行中（未招募）
1 期
A research study to compare a medicine called semaglutide against placebo in people with peripheral arterial disease and type 2 diabetesPeripheral arterial diseaseDiabetes Mellitus, Type 2MedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-003399-38-DKovo Nordisk A/S800